Interleukin-33 from oligodendrocytes sustains effector differentiation of tissue-resident CD8+ T cells and is a druggable target in CNS autoimmune disease
Nicolas Fonta(University of Geneva), Doron Merkler(University of Geneva)
Cited by 0
Related Papers
Late motor decline after accomplished remyelination: Impact for progressive multiple sclerosis
|Annals of Neurology|2011|108
Resident-Memory T Cells in Tissue-Restricted Immune Responses: For Better or Worse?
|Frontiers in Immunology|2018|88